6221 - 6230 of 8620 Results
Title
Year
-
OPENTitle: The End Is the Beginning: Parkinson’s Disease in the Light of Brain ImagingJournal Name: Frontiers in Aging NeurosciencePublisher: Frontiers Media SAVol: 9Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnagi.2017.00330Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnagi.2017.00330/pdfCitation Count: 34
- Chemogenomic Profiling of Endogenous PARK2 Expression Using a Genome-Edited Coincidence Reporter2015OPENTitle: Chemogenomic Profiling of Endogenous PARK2 Expression Using a Genome-Edited Coincidence ReporterJournal Name: ACS Chemical BiologyPublisher: American Chemical Society (ACS)Vol: 10Issue #: 5Start Page: 1188End Page: 1197Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1021/cb5010417Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/9927027Citation Count: 55
- Phosphorylated α-synuclein-immunoreactive retinal neuronal elements in Parkinson's disease subjects2014OPENTitle: Phosphorylated α-synuclein-immunoreactive retinal neuronal elements in Parkinson's disease subjectsJournal Name: Neuroscience LettersPublisher: Elsevier BVVol: 571Issue #:Start Page: 34End Page: 38Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neulet.2014.04.027Citation Count: 130
- Comparison of neuropathology in Parkinson's disease subjects with and without deep brain stimulation2016RESTRICTEDTitle: Comparison of neuropathology in Parkinson's disease subjects with and without deep brain stimulationJournal Name: Movement DisordersPublisher: WileyVol: 32Issue #: 2Start Page: 274End Page: 277Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.26882Citation Count: 29
- R1441C and G2019S LRRK2 knockin mice have distinct striatal molecular, physiological, and behavioral alterations2022OPENTitle: R1441C and G2019S LRRK2 knockin mice have distinct striatal molecular, physiological, and behavioral alterationsJournal Name: Communications BiologyPublisher: Springer Science and Business Media LLCVol: 5Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1038/s42003-022-04136-8Best OA location URL: https://www.nature.com/articles/s42003-022-04136-8.pdfCitation Count: 18
- LUBAC assembles a ubiquitin signaling platform at mitochondria for signal amplification and transport of NF‐κB to the nucleus2022OPENTitle: LUBAC assembles a ubiquitin signaling platform at mitochondria for signal amplification and transport of NF‐κB to the nucleusJournal Name: The EMBO JournalPublisher: Springer Science and Business Media LLCVol: 41Issue #: 24Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.15252/embj.2022112006Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.15252/embj.2022112006Citation Count: 26
- Brain-derived and in vitro-seeded alpha-synuclein fibrils exhibit distinct biophysical profiles2024OPENTitle: Brain-derived and in vitro-seeded alpha-synuclein fibrils exhibit distinct biophysical profilesJournal Name: eLifePublisher: eLife Sciences Publications, LtdVol: 13Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.7554/elife.92775Best OA location URL: https://doi.org/10.7554/elife.92775Citation Count: 3
- Identification of cholinergic centro-cingulate topography as main contributor to cognitive functioning in Parkinson’s disease: Results from a data-driven approach2022OPENTitle: Identification of cholinergic centro-cingulate topography as main contributor to cognitive functioning in Parkinson’s disease: Results from a data-driven approachJournal Name: Frontiers in Aging NeurosciencePublisher: Frontiers Media SAVol: 14Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnagi.2022.1006567Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnagi.2022.1006567/pdfCitation Count: 10
- Generation of gene-corrected isogenic controls from Parkinson's disease patient iPSC lines carrying the pathogenic SNCA p.A53T variant2023OPENTitle: Generation of gene-corrected isogenic controls from Parkinson's disease patient iPSC lines carrying the pathogenic SNCA p.A53T variantJournal Name: Stem Cell ResearchPublisher: Elsevier BVVol: 69Issue #:Start Page: 103125End Page: 103125Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.scr.2023.103125Best OA location URL: https://doi.org/10.1016/j.scr.2023.103125Citation Count: 1
- MTOR Pathway-Based Discovery of Genetic Susceptibility to L-DOPA-Induced Dyskinesia in Parkinson’s Disease Patients2018RESTRICTEDTitle: MTOR Pathway-Based Discovery of Genetic Susceptibility to L-DOPA-Induced Dyskinesia in Parkinson’s Disease PatientsJournal Name: Molecular NeurobiologyPublisher: Springer Science and Business Media LLCVol: 56Issue #: 3Start Page: 2092End Page: 2100Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s12035-018-1219-1Citation Count: 21